EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
2.4.1.288 | more |
GlfT2 is promiscuous in its substrate preferences. It preferentially acts on substrates in which the lipid-bearing Gal residue is connected to the sequence by a (1->6)-beta-glycosidic linkage. The preferential formation of alternating (1->6)-beta-Galf and (1->5)-beta-Galf residues arises not from substrate binding but during catalytic processive polymerization |
Mycobacterium tuberculosis |
? |
- |
- |
2.4.1.288 | more |
GlfT2 mediates synthesis of the galactan polymer, which contains between 20 and 40 D-galactofuranose residues connected by alternating beta-D-galactofuranosyl-(1->5)-D-galactofuranose and beta-D-galactofuranosyl-(1->6)-D-galactofuranose linkages. Elongation occurs by addition of D-galactofuranose residues from UDP-alpha-D-galactofuranose to the nonreducing end of a lipid-linked acceptor |
Mycobacterium tuberculosis H37Rv |
? |
- |
? |
2.4.1.288 | more |
no activity with 4-phenoxy-but-2-enyl beta-D-galactofuranosyl-(1->6)-beta-D-galactofuranoside |
Mycobacterium tuberculosis H37Rv |
? |
- |
? |
2.4.1.288 | more |
GlfT2 is promiscuous in its substrate preferences. It preferentially acts on substrates in which the lipid-bearing Gal residue is connected to the sequence by a (1->)-beta-glycosidic linkage. The preferential formation of alternating (1->6)-beta-Galf and (1->5)-beta-Galf residues arises not from substrate binding but during catalytic processive polymerization |
Mycobacterium tuberculosis ATCC 25618 |
? |
- |
- |
2.4.1.288 | more |
GlfT2 is promiscuous in its substrate preferences. It preferentially acts on substrates in which the lipid-bearing Gal residue is connected to the sequence by a (1->6)-beta-glycosidic linkage. The preferential formation of alternating (1->6)-beta-Galf and (1->5)-beta-Galf residues arises not from substrate binding but during catalytic processive polymerization |
Mycobacterium tuberculosis ATCC 25618 |
? |
- |
- |
2.4.1.288 | UDP-2''-O-methyl-alpha-D-galactofuranose + beta-Galf-(1->5)-beta-Galf-(1->6)-beta-Galf-octyl |
- |
Mycobacterium tuberculosis |
UDP + ? |
- |
? |
2.4.1.288 | UDP-3''-deoxy-alpha-D-xylo-hexofuranose + beta-Galf-(1->5)-beta-Galf-(1->6)-beta-Galf-octyl |
- |
Mycobacterium tuberculosis |
UDP + ? |
- |
? |
2.4.1.288 | UDP-3-deoxy-alpha-D-threo-hexofuranose + beta-Galf-(1->5)-beta-Galf-(1->6)-beta-Galf-octyl |
- |
Mycobacterium tuberculosis |
UDP + ? |
- |
? |
2.4.1.288 | UDP-5''-O-methyl-alpha-D-galactofuranose + beta-Galf-(1->5)-beta-Galf-(1->6)-beta-Galf-octyl |
- |
Mycobacterium tuberculosis |
UDP + ? |
- |
? |
2.4.1.288 | UDP-5-deoxy-alpha-D-galactofuranose + beta-Galf-(1->5)-beta-Galf-(1->6)-beta-Galf-octyl |
- |
Mycobacterium tuberculosis |
UDP + ? |
- |
? |